ITM-91 is under clinical development by ITM Isotope Technologies Munich and currently in Phase II for Metastatic Colorectal Cancer.
Ascentage’s olverembatinib gains approval in Macau for leukaemia
Ascentage Pharma’s olverembatinib is indicated for the treatment of haematological malignancy indications. Credit: Nemes Laszlo / Shutterstock. Ascentage Pharma has obtained approval for its new